【里昂：维持京东健康(06618.HK)“跑赢大市”评级 上半年业绩符预期】智通财经APP获悉，里昂发布研报称，基于强劲销售动能，将京东健康(06618.HK)2025及26年经调整净利润预测分别上调15%及13%，维持“跑赢大市”评级。该行预期2025年下半年公司收入将同比增长16%，由药品销售增长逾25%所带动，料营业补充品销售亦有高十位数同比增长，经调整EBIT或同比持平，因公司持续投入于O2O业务、线下药房及AI。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.